NASDAQ:IPA - ImmunoPrecise Antibodies Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$8.54
▼ -4.68 (-35.40%)

This chart shows the closing price for IPA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ImmunoPrecise Antibodies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IPA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IPA

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for ImmunoPrecise Antibodies in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $8.54.

This chart shows the closing price for IPA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in ImmunoPrecise Antibodies.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2021Industrial Alliance SecuritiesDowngradeBuy ➝ HoldLow
(Data available from 7/23/2016 forward)
ImmunoPrecise Antibodies logo
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. The company has collaboration with Eurofins Discovery to develop antibody discovery platform. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Read More

Today's Range

Now: $8.54
Low: $7.95
High: $10.68

50 Day Range

MA: $6.89
Low: $5.14
High: $13.22

52 Week Range

Now: $8.54
Low: $5.00
High: $33.34

Volume

9,227,831 shs

Average Volume

1,019,890 shs

Market Capitalization

$164.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ImmunoPrecise Antibodies?

The following Wall Street sell-side analysts have issued research reports on ImmunoPrecise Antibodies in the last twelve months: Industrial Alliance Securities.
View the latest analyst ratings for IPA.

What is the current price target for ImmunoPrecise Antibodies?

0 Wall Street analysts have set twelve-month price targets for ImmunoPrecise Antibodies in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ImmunoPrecise Antibodies in the next year.
View the latest price targets for IPA.

What is the current consensus analyst rating for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in IPA, but not buy more shares or sell existing shares.
View the latest ratings for IPA.

What other companies compete with ImmunoPrecise Antibodies?

How do I contact ImmunoPrecise Antibodies' investor relations team?

The company's listed phone number is 701 353 0022. The official website for ImmunoPrecise Antibodies is www.immunoprecise.com.